Older NSAIDs safer than new ones, study finds

11/4/2008 | HealthDay News

A study of 8,852 people who experienced heart attacks showed that nonsteroidal anti-inflammatory drugs that target the Cox-2 enzyme, such as Bextra and Celebrex, raised heart risk by 60%, compared with an 18% higher risk for NSAIDs that zero in on the Cox-1 enzyme, such as ibuprofen and naproxen. The findings support "the theory that each drug must be judged on an individual basis," but the study did not account for factors including blood-pressure levels, a heart specialist said.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT